> ## Content Index
> Fetch the complete content index at: https://www.missionviewpoint.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Where Clinical and Production Goals Meet
- URL: https://www.missionviewpoint.com/where-clinical-and-production-goals-meet/
- Published: 2026-11-17T23:06:30.000Z
- Updated: 2026-11-17T23:42:43.000Z
- Author: Scott Dickson
- Tags: Topic: Enterprise Data

*Part Two of MissionViewpoint's series:* **Can You Explain Your Hours?**

A clinic can miss its production target because it is delivering exactly the treatment its clinicians recommend.

Another can exceed its target without being able to show why its patients need more treatment.

From a distance, production and clinical progress can look like the same landmark. A production scorecard can't distinguish either of those clinics from one where clinical and operational measures are moving together. It records the result without explaining what produced it.

[*When the Hours Don't Match*](https://www.missionviewpoint.com/when-the-hours-dont-match/) proposed a one-patient test: can your team reconstruct why a single patient's hours changed, connecting clinical recommendations, authorization decisions, delivered treatment, and clinical progress? It also described where that record could live and the few missing pieces worth capturing, most importantly, the reasons behind each change.

This article asks what an organization could learn from that record across hundreds of patients, multiple clinics, and different payors.

## Taking the Hours Apart

Delivered hours look like a single number. They're actually the product of four factors:

**Patients in treatment × Average recommended intensity × Share of recommended hours authorized × Share of authorized hours delivered**

The factors must cover the same period, patient population, and services. The authorization and delivery shares are calculated from total hours, rather than averaging individual patient percentages.

Each factor moves for different reasons and points to a different part of the organization. Patient counts reflect intake, capacity, and discharge. Average recommended intensity reflects clinical recommendations and changes in patient mix. The authorized share reflects payor decisions. The delivered share reflects staffing, scheduling, cancellations, and family availability.

Not every provider stores recommended intensity as a structured number; it often lives in treatment plan documents. But hours requested in authorization submissions are already part of the workflow and can serve as a practical starting proxy, provided differences between requested and clinically recommended hours are understood.

Conventional reporting often collapses these factors into production and utilization. That's why two very different clinicscan look identical.

Consider two hypothetical clinics, each reporting 95% authorization utilization, each with a 25% decline in average delivered treatment intensity among continuing patients over the past year.

Taken apart, the declines sit in different places. At Clinic A, recommended intensity fell, mostly following documented clinical reassessments. At Clinic B, recommended intensity held steady, but the authorized share fell following payor restrictions that clinicians believed were inconsistent with patients' needs.

Both clinics continue delivering nearly all their authorized hours. Utilization alone doesn't reveal that one decline originated in clinical recommendations and the other in payor decisions.

**Same utilization, same decline, different factor, different reason.**

One clinic raises questions about whether clinically directed reductions are working as intended. The other raises questions about patients' access to the care their clinicians recommend.

Growth needs the same examination. Suppose a third clinic's delivered hours rose approximately 15% over the year:

![](https://storage.ghost.io/c/3e/92/3e927a59-e12c-40f3-95a3-d8827ecd5400/content/images/2026/11/Screenshot-2026-11-17-145442-1.png)

Together, those changes produce approximately 14.6% growth in delivered hours.

The patient growth and improved delivery suggest operational changes worth understanding, such as greater intake capacity or fewer cancellations. The 5% increase in average recommended intensity is adifferent kind of finding. It could reflect changes in the mix of patients receiving treatment, reassessments identifying greater needs among existing patients, or other changes in clinical recommendations.

The breakdown doesn't answer why recommended intensity increased. **It isolates the change so leadership knows where to look.**

The same approach applies to performance against plan. A clinic that misses its production target could distinguish how much of the shortfall came from clinically directed reductions, how much from payor decisions, and how much from staffing or scheduling constraints — three different explanations for the same financial variance.

Two practical requirements make this work.

First, intensity must be compared across comparable services and periods. Direct therapy, supervision, and caregiver training move for different reasons, and a change in service mix can masquerade as a change in intensity when those services are blended together.

Second, each material change needs the explanation [Part One](https://www.missionviewpoint.com/when-the-hours-dont-match/) argued for preserving: clinical reassessment, payor decision, staffing, family availability, or another documented reason.

That creates a useful measure of its own:

**How much of the change in delivered hours can the organization explain with retrievable, supporting evidence?**

A structured field identifying "clinical reassessment" is a starting point, not necessarily a complete explanation. The underlying recommendation, relevant assessment, and effective date should be available when someone needs to understand what happened.

A provider that can substantiate most of a year's changes is in a different position, with its own leadership and with payors, than one that must reconstruct explanations from scattered records.

The most valuable addition isn't another KPI. It's the ability to break existing measures down by the factor that moved and the reason it moved.

## Capturing the Circumstances Behind the Change

Breaking delivered hours into four factors helps explain where production changed. But to understand why it changed, providers need something more specific than a number or a note buried in a treatment plan.

They need a consistent way to identify the circumstances affecting treatment intensity and delivery as those circumstances occur.

That doesn't necessarily require another application. In Part One, I described three approaches: configuring the existing EHR or practice management system, connecting records through a shared data store, or extending an enterprise data platform.

**Any of those could support a relatively simple tagging framework.**

Consider five categories of circumstances:

- **Clinical Delivery:** Reassessment, increased recommended intensity, clinically directed fading, treatment plan revision, or changing clinical needs.
- **Authorization:** Approval below requested hours, authorization increase or reduction, delayed approval, or pending appeal.
- **Staffing and scheduling:** Staff unavailable, turnover, unfilled sessions, scheduling conflict, or restored capacity.
- **Family and patient:** Cancellations, illness, changing family availability, requested schedule reduction, or treatment interruption.
- **Clinical measurement:** New assessment available, meaningful change in measured progress, or reassessment indicated.

These aren't mutually exclusive categories. A patient may experience an authorization reduction and a staffing shortage during the same period. A clinician may revise the treatment recommendation while family availability is also changing.

Each material change could create a patient-level event associated with the relevant service, effective date, observed change, and supporting record. The event could carry multiple tags, supplied automatically where the data supports them or by the person who knows what happened.

This creates a consistent history of treatment changes without requiring every circumstance to fit into a single explanation.

Some events can be captured automatically. A new authorization can trigger a comparison with the previous authorization and the clinician's recommendation. Scheduling systems may already record cancellations and staffing-related shortfalls.

Others require a person who knows what happened. A BCBA may document clinically directed fading following reassessment. A scheduler may identify a sustained change in family availability. An authorization specialist may record that a clinician disagreed with a payor restriction.

Clinical measurement tags serve a slightly different purpose. A new assessment or a meaningful change in measured progress identifies new evidence, not necessarily the reason treatment intensity changed. That connection should be documented by the clinician rather than inferred from the measurement alone.

Where the relevant information lives in unstructured treatment plans or notes, AI could help recognize when a change has occurred without an explanation and prompt the right person to supply one while it's still known.

For example, an authorization reduction could be detected automatically, while an unexplained decline in delivered hours might prompt a scheduler to identify whether staffing or family availability contributed. A change in recommended intensity could prompt the supervising clinician to confirm the reason and connect the relevant documentation.

Many of these events can be detected using conventional rules. AI becomes particularly useful when finding information across unstructured records or identifying where an explanation is missing.

Its role is to notice gaps in the record, not to invent explanations or make clinical judgments.

The goal is to capture a small amount of structured context at the point where someone already knows why a change occurred, without creating another documentation burden.

A tag alone isn't sufficient evidence. "Clinical reassessment" should link to the relevant treatment plan or assessment. "Staff unavailable" should be supported by scheduling records. And when the explanation isn't known, that should remain visible rather than being replaced by an assumption.

Consider two patients whose delivered treatment falls from 25 to 15 hours per week.

For one, the clinician revised the recommendation following reassessment. For the other, the clinical recommendation remained unchanged while the payor reduced the authorization.

The production change is identical. The circumstances are not.

**Capturing those distinctions at the patient level creates a more reliable foundation for understanding treatment intensity across an organization.**

It also means that when leadership needs to examine a change months later, the relevant circumstances and supporting records are already connected rather than reconstructed from memory.

## Lining Hours Up With Progress

Taking the hours apart helps explain production. Capturing the circumstances behind individual changes provides context for how those changes occurred. Neither establishes whether treatment intensity was clinically appropriate or how patients progressed.

That requires a second view: examining treatment intensity alongside longitudinal clinical measurements.

![](https://storage.ghost.io/c/3e/92/3e927a59-e12c-40f3-95a3-d8827ecd5400/content/images/2026/11/Screenshot-2026-11-17-145211-1.png)

Each pattern has more than one plausible explanation, and the circumstances captured at the patient level help narrow the questions.

A decrease in intensity accompanied by continued progress means something different when clinicians recommended the reduction than when it resulted from an authorization restriction. An increase in intensity with limited measured progress raises different questions when the increase reflects newly identified clinical needs than when the underlying recommendation hasn't changed.

The practical difficulty is aligning the information.

Standardized assessments such as the Vineland are administered on schedules that may not match authorization periods. Program-level goal data may be collected more frequently but is specific to each patient's treatment plan.

One practical approach is to examine the interval between assessments, connecting the treatment recommended, authorized, and delivered during that interval with the measurements available at its beginning and end.

Standardized and program-specific measures answer different questions, though, and shouldn't be blended into a single progress score.

Comparisons across patients also require reasonably comparable cohorts. Age, baseline clinical characteristics, time in treatment, service mix, and other relevant differences can materially affect the interpretation.

And one caveat applies throughout: changes in clinical measurements may reflect development, concurrent services, family circumstances, or other factors. **When treatment intensity and progress move together, one does not necessarily cause the other.**

These patterns identify questions; they don't establish clinical conclusions.

Within those limits, the comparisons become useful. A provider could examine whether patients consistently receiving less treatment than clinicians recommend show different subsequent progress patterns from comparable patients receiving the recommended intensity, then investigate whether those differences are associated with a particular payor, clinic, or persistent staffing constraint.

That creates a more informative picture of access to care than authorization utilization alone provides.

## What the Population Shows

Some patterns only become visible at scale.

A single patient's reduced authorization is a case. The same payor consistently authorizing a lower share of recommended hours across successive periods, for comparable patients, is a pattern.

So is recommended intensity that differs materially between regions for similar patient cohorts, an access shortfall concentrated in after-school appointments, or clinically directed reductions that consistently appear in management reporting as production failures.

**None of these observations establishes that something is wrong.** Each is something leadership should be able to examine — yet producing these comparisons may require reconstructing information scattered across clinical, authorization, scheduling, and billing systems.

The [Wall Street Journal's October analysis](https://www.missionviewpoint.com/aba-never-built-a-common-utilization-benchmark-the-wall-street-journal-did/) is a reminder of who else is looking. Its comparison of treatment intensity before and after children changed providers was a population-level pattern assembled from claims, outside the provider organization.

It's also the kind of change a provider should be able to examine internally, distinguishing patient needs, clinical recommendations, authorization decisions, and actual delivery before anyone draws conclusions.

The financial implications can be material in either direction.

Consider a hypothetical provider serving 500 patients. If clinicians appropriately reduce average weekly treatment intensity by two hours per patient, that's 1,000 fewer weekly hours, assuming those hours would otherwise have been delivered.

At an illustrative average collected reimbursement of $75 per hour, that represents $75,000 in weekly revenue before considering staffing adjustments, replacement demand, or other operating changes.

Clinically, the reductions may be entirely appropriate. On a production scorecard, they register as a miss.

But should a clinic be considered underperforming because its clinicians determined that patients needed less treatment?

The opposite deserves equal scrutiny. An increase of the same magnitude would look favorable on the production scorecard, even if leadership couldn't readily explain the clinical recommendations behind it.

ABA providers need sustainable revenue to recruit clinicians, maintain capacity, and expand access. Financial performance is not optional.

**But a production target should not become the standard against which clinical recommendations are judged.**

A clinically appropriate reduction may free capacity to serve another patient. It may also reduce revenue without an immediate opportunity to replace it. Those are legitimate operating and financial consequences that leadership needs to understand.

The distinction matters for budgets, capacity planning, and performance incentives. If clinic managers are evaluated primarily on delivered hours, a clinically appropriate reduction can look like poor performance. If increases in recommended intensity are treated as production wins, leadership may overlook questions that deserve clinical examination.

**The same information that helps explain patient care may also challenge how the organization defines operational success.**

That is a more consequential use of connected data than simply producing a better utilization report.

## Bringing It Into Focus

Traditional production measures remain essential to running an ABA organization. But on their own, they can't distinguish clinically directed reductions from access problems, growth in patient counts from growth in treatment intensity, or explain how either relates to patient progress.

Taking delivered hours apart by factor and documented reason, capturing the circumstances behind individual treatment changes, and examining those changes alongside longitudinal clinical measurements creates a more consistent foundation for understanding treatment intensity across patients, clinics, and payors.

Some findings will reinforce existing assumptions about performance. Others may challenge them.

A clinic missing its production target may be delivering precisely the care its clinicians recommend. Another exceeding its target may need to explain why treatment intensity is increasing.

Neither finding automatically calls for a correction. Both deserve an explanation grounded in the clinical and operational record.

**The numbers tell you what changed.** The connected record tells you what circumstances produced the change. Neither, on its own, tells you what the organization should do next.

Determining how to use this information to identify meaningful patterns, prioritize reviews, assign accountability, and act when clinical and financial priorities diverge is the subject of the final article in this series: *When the Data Demands a Decision*.

---

If this analysis is useful, you can subscribe to receive future SCUBA updates and related insights through the [MissionViewpoint newsletter](https://www.missionviewpoint.com/#/portal/signup).

Prefer LinkedIn? Subscribe [here](https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7306701768954892288&ref=missionviewpoint.com).